Haemophilia, Peyvandi (UniMi): "Bispecific Farmaceans Have Changed the Lives of Patients"
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.6 Articles
6 Articles
The life of patients with haemophilia has changed significantly over the last ten years. In patients who had antibodies against factor VIII, so-called inhibitors, the quality of life was very low: they had continuous bleeding and therapy was not effective. The use of new bispecific drugs, bioengineering molecules...Read moreThe article Hemophilia, Peyvandi (UniMi):
(Adnkronos) - “The lives of patients with hemophilia in the last ten years have changed significantly. In patients who had antibodies against factor VIII - so-called inhibitors - the quality of life was really low: they had continuous bleeding and the therapy was not effective. The use of new bispecific drugs”, bioengineering molecules [...] The article Hemophilia, Peyvandi (UniMi): “Bispecific drugs have changed patients' lives” comes from Rec …
Giornale Radio
"The lives of patients with haemophilia in the last ten years have changed significantly. In patients who had antibodies against factor VIII - the so-called inhibitors - the quality of life was really low: they had continuous bleeding and therapy was not effective. Using new bispecific drugs" - bioengineering molecules designed to bind two different targets at the same time, "has completely changed their lives."
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
